ID24649A - Replikon virus epstein-barr kompak - Google Patents

Replikon virus epstein-barr kompak

Info

Publication number
ID24649A
ID24649A IDW991631A ID991631A ID24649A ID 24649 A ID24649 A ID 24649A ID W991631 A IDW991631 A ID W991631A ID 991631 A ID991631 A ID 991631A ID 24649 A ID24649 A ID 24649A
Authority
ID
Indonesia
Prior art keywords
replikon
kompak
barr
virus epstein
nucleic acid
Prior art date
Application number
IDW991631A
Other languages
English (en)
Indonesian (id)
Inventor
Brian Seed
Original Assignee
Gen Hospital Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gen Hospital Corp filed Critical Gen Hospital Corp
Publication of ID24649A publication Critical patent/ID24649A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/10—Plasmid DNA
    • C12N2800/108—Plasmid DNA episomal vectors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IDW991631A 1997-06-19 1998-04-14 Replikon virus epstein-barr kompak ID24649A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US5020697P 1997-06-19 1997-06-19

Publications (1)

Publication Number Publication Date
ID24649A true ID24649A (id) 2000-07-27

Family

ID=21963948

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW991631A ID24649A (id) 1997-06-19 1998-04-14 Replikon virus epstein-barr kompak

Country Status (20)

Country Link
US (1) US6133025A (es)
EP (1) EP1032418B1 (es)
JP (1) JP2002505586A (es)
KR (1) KR100569826B1 (es)
CN (1) CN1263861C (es)
AR (1) AR054291A1 (es)
AT (1) ATE270341T1 (es)
AU (1) AU744680B2 (es)
BR (1) BR9810055A (es)
CA (1) CA2293299A1 (es)
DE (1) DE69824881T2 (es)
DK (1) DK1032418T3 (es)
ES (1) ES2224382T3 (es)
HU (1) HUP0003971A3 (es)
ID (1) ID24649A (es)
PL (1) PL337528A1 (es)
PT (1) PT1032418E (es)
RU (1) RU2240348C2 (es)
TR (1) TR199903155T2 (es)
WO (1) WO1998057658A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002257440A1 (en) * 2001-05-07 2002-11-18 National Research Council Of Canada Enhanced production of recombinant proteins by transient transfection of suspension-growing mammalian cells
EP2285969B1 (en) 2008-05-15 2013-01-16 National Research Council Of Canada Use of protein kinase b and valproic acid to increase heterologous gene expression in mammalian cells

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4939088A (en) * 1987-02-18 1990-07-03 Meloy Laboratories Inc. Sustained production of recombinant gamma interferon using an Epstein-Barr virus replicon

Also Published As

Publication number Publication date
AU7123998A (en) 1999-01-04
DK1032418T3 (da) 2004-11-01
BR9810055A (pt) 2000-09-12
HUP0003971A2 (en) 2001-03-28
CA2293299A1 (en) 1998-12-23
RU2240348C2 (ru) 2004-11-20
KR100569826B1 (ko) 2006-04-11
TR199903155T2 (en) 2000-09-21
WO1998057658A1 (en) 1998-12-23
PL337528A1 (en) 2000-08-28
PT1032418E (pt) 2004-10-29
DE69824881T2 (de) 2004-11-18
EP1032418B1 (en) 2004-06-30
AR054291A1 (es) 2007-06-20
AU744680B2 (en) 2002-02-28
KR20010013901A (ko) 2001-02-26
US6133025A (en) 2000-10-17
ES2224382T3 (es) 2005-03-01
ATE270341T1 (de) 2004-07-15
EP1032418A1 (en) 2000-09-06
HUP0003971A3 (en) 2003-03-28
CN1278185A (zh) 2000-12-27
JP2002505586A (ja) 2002-02-19
CN1263861C (zh) 2006-07-12
EP1032418A4 (en) 2002-01-02
DE69824881D1 (de) 2004-08-05

Similar Documents

Publication Publication Date Title
MY117686A (en) Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof
GR3024597T3 (en) 7-deazapurine modified oligonucleotides
DE69400208D1 (en) Olionukleotidalkylphosphonate und -phosphonothioate
EP0484374A4 (en) Rapid, versatile and simple system for expressing genes in eukaryotic cells
ZA957797B (en) Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell
AU4266597A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
DK1681355T3 (da) Sekvensspecifik DNA-rekombination i eukaryote celler
AU3675095A (en) Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell
DK338788A (da) Fremgangsmaade til transformering af celler
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
ID24649A (id) Replikon virus epstein-barr kompak
DK0596881T3 (da) Ekspression i ikke-tumurale humane lymofoblastoider med en integrativ vektor
EA199900144A1 (ru) Способ индуцирования вирусной устойчивости в растении
EP0154566A3 (en) Viral enhancer dna segments
ATE259421T1 (de) Dna-virus-vektoren und verfahren zu ihrer herstellung
CO5270027A1 (es) Tecnica de transfeccion intensificada
HUP0102517A2 (hu) INFA2 kódoló régiójától 5' -irányban található genomi eredetű szekvenciák, alkalmazásuk INFA2-bevitelre alkalmas gyógyszerek előállítására, valamint eljárások INFA2 előállítására
DK204586D0 (da) Hybridceller, der producerer et karakteristisk antigen for hepatitis b-virus, opnaaet ud fra hepatocytter og celler, der er tilvejebragt fra aber, fremgangsmaade til opnaaelse af hybridcellerne og anvendelse af disse til produktion af antigenet
Wakaida Study of axial plasma confinement in axisymmetrized tandem mirror GAMMA 10
ATE46264T1 (de) Thymidinkinase-negativ-temperaturbestaendiger rinder herpes-virus-1-mutant als vakzin gegen infektioese rinder-rhinotracheitis.
UA9690A (uk) Індуктор інтерферону першого типу в культурах клітин